Dr. Peter Memminger

• Sale of the Waygate business by Baker Hughes to Hexagon
• A number of BioTech/Life Sciences related investments and transactions such as the sale of GNA Biosolutions to HP or financing rounds of Hummingbird Diagnostics, Verovaccines or neoplas
• French Sidetrade SA, the global leader in AI-powered Order-to-Cash applications, on the acquisition of SHS Viveon AG, a German public listed company
• French software developer Dassault Systèmes SE on the purchase of ASCon Systems Holding GmbH
• Engel Austria on the acquisition of Trexel, Inc.
• Crosslantic Capital Management in connection with the investment and shareholding into MILES, a German mobility provider
• Wellspring Worldwide Inc. on the acquisition of all the shares of UK-listed company Sopheon plc
• Acton Capital Partners as lead investor in the financing of Saas.group, a Nevada-based software aggregator
• UltraGreen.ai as local counsel in connection with USD 400M IPO
• Keyloop, a portfolio company of Francisco Partners, on the acquisition of 100% of the shares of Automotive Transformation Group, a UK provider of automotive technology
• Lead advisor to asset manager Kartesia on the acquisition of the German advisory and corporate finance firm goetzpartners group
• Crosslantic Capital on a number of transactions in Germany and abroad
• Shareholders of Global Healthy Living Products on the sale to Semcap
• A large hedge fund and major shareholder in Deutsche Wohnen concerning the takeover by Vonovia
• Advising the shareholders on the restructuring of IFA Automotive and subsequent sale
• Summit Partners on various transactions concerning the Global Gruppe, ZahnEins and others
• Shareholders of CommitMed on the sale to EQT and subsequent reinvestment
• Shareholders of Gingko on the sale to Deutsche Private Equity
• FSN Capital on the acquisition of a major infrastructure related asset
• Sale of Märsch Importhandels GmbH by Märsch GbR to Olam Nutrition Ingredients
• Lead advisor on the fundraising and implementation of fund structure for a leading European growth fund
• In court representation of one of the largest European private equity funds in connection with the successful removal of a preliminary injunction over its shares in a worldwide industrial conglomerate against unsecured creditors in various jurisdictions
• In court representation of a restructuring fund in connection with lawsuit against seller of distressed asset for lack of due disclosure
• Sale of Greenland Seafood group for Asian based investors to UK private equity fund CapVest
• Family Office of Prof. Dr. h.c. Roland Berger on various acquisitions and disposals
• Alexander Rittweger on the sale of Loyalty Partner and various investments in start-ups in Germany and abroad
• Vitruvian Partners on the acquisition and sale of the Linimed/Fazmed Group
• Various other (international) funds, family offices and companies such as Apax, Advent, Carlyle or Tennebaum Capital Partners on various transactions and matters

Peter Memminger heads its M&A/Private Equity practice in Germany. Peter focuses on (public) M&A, corporate and litigation work on behalf of private equity funds, family offices and large corporates. He helps clients with a broad range of domestic and global transactions various industries and also advises them  on restructurings, corporate governance issues and transaction-related disputes, both in-court and out-of-court. While being industry agnostic, he has developed special expertise in software, life sciences and food transactions.

With more than 25 years of experience, Peter represents private equity funds, family offices and leading corporates across various industries in their domestic and cross-border mergers and acquisitions and complex restructuring and insolvency matters. He has handled more than 400 transactions with an aggregate deal value of more than EUR 30 billion. Peter also has extensive experience with representing clients in litigation matters arising out of his corporate and finance-related work and, on behalf of clients, has handled some of the largest corporate disputes in Germany to date. Clients appraise him for his unique combination of strong legal skills and strategic thinking with a deep economic understanding of the value drivers of transactions and negotiations.

For more than a decade, Peter has been ranked among the leading M&A and Private Equity lawyers by leading guides such as Chambers, Legal 500, JUVE, IFLR, Handelsblatt/Best Lawyers and others. He regularly speaks on M&A topics and lectures on international law and M&A at Hochschule Fresenius. Peter is a former Regional Ambassador for INSEAD's International Directors Program (IDP) in Germany and serves as member of various supervisory and advisory boards in Germany and abroad.

Prior to joining King & Spalding, Peter founded his own boutique firm and merged it with the leading German litigation boutique to form Bub Memminger. Prior to establishing his own firm, Peter was a partner at Milbank, where he successfully established and expanded the corporate division, back then one of the youngest equity partners worldwide. Before working as a lawyer, Peter worked as an assistant to the board in the M&A department at JPMorgan Chase & Co. He also was a partner at a German restructuring fund and served on its investment committee from 2017 to 2020.